{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:58:11Z","timestamp":1790492291505,"version":"4.1.0"},"reference-count":40,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cell Transplant"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    Pluripotent adipose-derived stem cells (PASCs) are a non-tumorigenic, stress-enduring SSEA-3\n                    <jats:sup>+<\/jats:sup>\n                    cell population sharing key biological markers with Muse cells while representing a phenotypically distinct population. This Phase IIa randomized, double-blind, placebo-controlled pilot trial evaluated the safety, feasibility, and exploratory clinical effects of intravenous PASCs in Parkinson\u2019s disease (PD). Forty participants with Hoehn and Yahr stages I\u2013III PD were randomized 1:1 to receive three intravenous infusions of PASCs (25 million cells) or placebo at baseline, month 3, and month 6, with 12-month follow-up. All participants underwent a structured neurological rehabilitation program. The primary endpoint was safety (CTCAE v5.0). No treatment-related adverse events of any grade were observed across 60 infusions. One thromboembolic event in the PASC group was independently adjudicated as of uncertain relationship to the study intervention, and one death in the placebo group was adjudicated as unrelated. For each of the seven exploratory functional and quality-of-life endpoints, the global treatment-by-time interaction was tested and adjusted for multiplicity using the Benjamini-Hochberg procedure; no endpoint reached significance after control of the false discovery rate (all q &gt; 0.05). Repeated intravenous PASC administration is safe and feasible in PD. Efficacy was not demonstrated in this pilot trial, and the exploratory findings are hypothesis-generating, supporting further investigation in adequately powered Phase IIb\/III trials.\n                  <\/jats:p>","DOI":"10.1177\/09636897261492438","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:28:59Z","timestamp":1790155739000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["A pilot phase IIa randomized, placebo-controlled, double-blind trial of intravenous human pluripotent adipose-derived stem cells (PASCs) in Parkinson\u2019s disease: The REPOSE study"],"prefix":"10.1177","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3864-529X","authenticated-orcid":false,"given":"Mar\u00eda Laura","family":"Gimeno","sequence":"first","affiliation":[{"name":"ClusterXStem Inc."},{"name":"IBioBA-MPSP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Chazenbalk","sequence":"additional","affiliation":[{"name":"ClusterXStem Inc."},{"name":"ClusterXStem Costa Rica"},{"name":"David Geffen School of Medicine at the University of California Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Riggioni","sequence":"additional","affiliation":[{"name":"NeuroFT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Ortega","sequence":"additional","affiliation":[{"name":"NeuroFT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Miranda","sequence":"additional","affiliation":[{"name":"Provida. Laboratorio de C\u00e9lulas Madre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Valverde","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednica B\u00edblica"},{"name":"The Regenerative Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9764-4192","authenticated-orcid":false,"given":"Jos\u00e9 A","family":"Molina-Mora","sequence":"additional","affiliation":[{"name":"Universidad de Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linette Gonz\u00e1lez","family":"Rojas","sequence":"additional","affiliation":[{"name":"ClusterXStem Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vargas","sequence":"additional","affiliation":[{"name":"ClusterXStem Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Zu\u00f1iga","sequence":"additional","affiliation":[{"name":"Hospital Internacional La Cat\u00f3lica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rosales","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednica B\u00edblica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5851-0287","authenticated-orcid":false,"given":"Freddy","family":"Henr\u00edquez","sequence":"additional","affiliation":[{"name":"Hospital Internacional La Cat\u00f3lica"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"e_1_3_9_2_2","first-page":"504","article-title":"Parkinson's disease and its management: part 1","volume":"40","author":"DeMaagd G","year":"2015","unstructured":"DeMaagd G, Philip A. Parkinson's disease and its management: part 1. P T 2015; 40: 504\u2013532.","journal-title":"P T"},{"key":"e_1_3_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01419-8"},{"key":"e_1_3_9_4_2","doi-asserted-by":"publisher","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"key":"e_1_3_9_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13"},{"key":"e_1_3_9_6_2","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.266268"},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28582"},{"key":"e_1_3_9_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2009.07.006"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202002944"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","DOI":"10.25259\/SNI_233_2020"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13547"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01037-x"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155241"},{"key":"e_1_3_9_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.09.014"},{"key":"e_1_3_9_15_2","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X14666190823142911"},{"key":"e_1_3_9_16_2","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2022.0312"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-023-00269-3"},{"key":"e_1_3_9_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112517"},{"key":"e_1_3_9_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131676"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064752"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2016-0014"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/2001-1326-3-12"},{"key":"e_1_3_9_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0674-3"},{"key":"e_1_3_9_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0578-1"},{"key":"e_1_3_9_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/09636897231214370"},{"key":"e_1_3_9_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03842-w"},{"key":"e_1_3_9_27_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0307"},{"key":"e_1_3_9_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17201"},{"key":"e_1_3_9_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X231202594"},{"key":"e_1_3_9_30_2","first-page":"1810","article-title":"Novel treatment for Parkinson's disease with intravenous allogeneic pluripotent non-tumorigenic adipose stem cell transplantation: a case report","volume":"9","author":"Chazenbalk G","year":"2024","unstructured":"Chazenbalk G, Meyers LR, Henriquez Varela F, et al. Novel treatment for Parkinson's disease with intravenous allogeneic pluripotent non-tumorigenic adipose stem cell transplantation: a case report. Ann Case Rep 2024; 9: 1810.","journal-title":"Ann Case Rep"},{"key":"e_1_3_9_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.0549"},{"key":"e_1_3_9_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"e_1_3_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.05.034"},{"key":"e_1_3_9_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13549"},{"key":"e_1_3_9_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-104"},{"key":"e_1_3_9_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2019.06.001"},{"key":"e_1_3_9_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2020.03.031"},{"key":"e_1_3_9_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057073"},{"key":"e_1_3_9_39_2","doi-asserted-by":"publisher","DOI":"10.4103\/sja.sja_158_21"},{"issue":"1","key":"e_1_3_9_40_2","first-page":"48","article-title":"TGF-\u03b21 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson's disease models and patients","volume":"11","author":"Zhuo Y","year":"2024","unstructured":"Zhuo Y, Li WS, Lu M, et al. TGF-\u03b21 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson's disease models and patients. Mil Med Res 2024; 11(1): 48.","journal-title":"Mil Med Res"},{"key":"e_1_3_9_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311648"}],"container-title":["Cell Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09636897261492438","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09636897261492438","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09636897261492438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:46:24Z","timestamp":1790491584000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09636897261492438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["10.1177\/09636897261492438"],"URL":"https:\/\/doi.org\/10.1177\/09636897261492438","relation":{},"ISSN":["0963-6897","1555-3892"],"issn-type":[{"value":"0963-6897","type":"print"},{"value":"1555-3892","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"article-number":"09636897261492438"}}